Sign inGet started

Wu Yue Alexander

Insider CIK 1682419 · SCLX Director · SRNE Director · CASI Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SCLX Scilex Holding Co A Award deriv2025-10-082025-10-0920,000— $020,000SEC↗
SCLX Scilex Holding Co A Award deriv2024-12-162024-12-17100,000— $0100,000SEC↗
SCLX Scilex Holding Co P Buy2024-10-172024-10-1820,000$0.95 $19.0K25,000SEC↗
SCLX Scilex Holding Co M Exercise deriv2024-06-202024-06-205,000— $0245,000SEC↗
SCLX Scilex Holding Co M Exercise2024-06-202024-06-205,000$1.41 $7.0K5,000SEC↗
SCLX Scilex Holding Co A Award deriv2023-10-042023-10-05250,000— $0250,000SEC↗
CASI CASI Pharmaceuticals, Inc. A Award deriv2022-05-252022-05-26388,387— $0388,387SEC↗
SRNE Sorrento Therapeutics, Inc A Award deriv2021-08-302021-08-30250,000— $0250,000SEC↗
CASI CASI Pharmaceuticals, Inc. A Award deriv2021-06-152021-06-16110,459— $0110,459SEC↗
CASI CASI Pharmaceuticals, Inc. A Award deriv2020-06-162020-06-1868,800— $068,800SEC↗
SRNE Sorrento Therapeutics, Inc A Award deriv2020-06-152020-06-15100,000— $0100,000SEC↗
CASI CASI Pharmaceuticals, Inc. A Award deriv2019-06-202019-06-2157,885— $057,885SEC↗
SRNE Sorrento Therapeutics, Inc A Award deriv2019-04-192019-04-2370,000— $070,000SEC↗
SRNE Sorrento Therapeutics, Inc A Award deriv2018-11-262018-11-2735,000— $035,000SEC↗
SRNE Sorrento Therapeutics, Inc A Award deriv2017-09-152017-09-1535,000— $035,000SEC↗
SRNE Sorrento Therapeutics, Inc A Award deriv2017-09-152017-09-1835,000— $035,000SEC↗
SRNE Sorrento Therapeutics, Inc P Buy2017-02-032017-02-035,000$5.15 $25.8K5,000SEC↗